It’s been a highly productive week in Southern California, with multiple on-site visits, strategic discussions, and participation in key scientific conferences. Here are the major highlights:

1️⃣ Collaboration Progress with UCSD Sanford Advanced Therapy Center

We visited the Sanford Advanced Therapy Center at UC San Diego and had an in-depth meeting with Professor D’s team.

• Confirmed initial collaboration intentions
• Identified three concrete collaboration tracks
• Established a timeline for next-step technical meetings

This marks an important step in FY BIO’s continued expansion in the advanced therapy (ATMP) field.

2️⃣ CTAD 2025: Alzheimer’s Research Remains a National Priority

Attended CTAD 2025 in San Diego, one of the most influential conferences in Alzheimer’s clinical research.

Key takeaways:

• AD continues to receive significant U.S. funding and strategic focus
• Increasing interest in biomarkers, digital tools, and trial innovation
• Engaged with several Biopharma teams, forming initial partnership opportunities

We see substantial long-term potential in the AD space.

3️⃣ NeurIPS 2025: AI Momentum Continues

Visited NeurIPS 2025, where AI again proved to be the center of global attention:

• Exceptional concentration of capital, talent, and innovation
• Limited biology-specific sessions, but
• Strong emerging opportunities in AI for bioprocessing, QC automation, and data-driven optimization

An area where FY BIO plans to further explore and integrate solutions.

4️⃣ SABPA Meeting: A Reflection on Resilience

Spoke with Marco Biamonte at the SABPA event.

Despite the economic downturn and U.S. federal funding reductions, many researchers and innovators continue pushing forward with admirable resilience.
Their commitment is what keeps the industry moving, even in challenging times.

5️⃣ PDA SoCal (Irvine): Expanding Our Local Network

At the PDA Southern California meeting, we:

• Engaged with experts in sterile manufacturing and process engineering
• Discussed potential collaborations with regional distributors
• Received strong interest in FY BIO’s single-use systems, chromatography materials, and filtration products

More follow-ups are planned in the coming weeks.